Kong Y, Dong Q, Jin P, Li MY, Ma L, Yi QJ, Miao YE, Liu HY, Liu JG. Inetetamab combined with S-1 and oxaliplatin as first-line treatment for human epidermal growth factor receptor 2-positive gastric cancer. World J Gastroenterol 2024; 30(40): 4367-4375 [PMID: 39494102 DOI: 10.3748/wjg.v30.i40.4367]
Please LOGIN to submit a new comment.